Sexual dimorphism in gene expression after aneurysmal subarachnoid hemorrhage

Neurological Research

Volumn 37, Issue 12, 2015, Pages 1054-1059

  Friedrich, Victor ^a   Bi, Weina ^a   Sehba, Fatima A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Early brain injury; Gender; Inflammation; Stroke; Vascular pathology

Indexed keywords

ARGIPRESSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ENOLASE; TUMOR NECROSIS FACTOR; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN BLOOD FLOW; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART RATE; INTRACRANIAL PRESSURE MONITORING; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; VASCULITIS; ANIMAL; BLOOD PRESSURE; BRAIN CIRCULATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; INTRACRANIAL PRESSURE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HEART RATE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTRACRANIAL PRESSURE; MALE; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; SUBARACHNOID HEMORRHAGE; THROMBOMODULIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84959346655     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1080/01616412.2015.1115211     Document Type: Article

References (41)

1. Vaartjes I, Reitsma JB, Berger-van Sijl M, et al. Gender differences in mortality after hospital admission for stroke. Cerebrovasc Dis. 2009;28:564–571.
2. Hamdan A, Barnes J, Mitchell P. Subarachnoid hemorrhage and the female sex: analysis of risk factors, aneurysm characteristics, and outcomes. J. Neurosurg. 2014;8:1–7.
3. Friedrich V, Bederson JB, Sehba FA. Gender influences the initial impact of subarachnoid hemorrhage; an experimental study. PLoS ONE. 2013;8:e80101.
4. Josko J, Gwozdz B, Jedrzejowska-Szypulka H, et al. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med. Sci. Monit. 2000;6:1047–1052.
5. Sun BL, Hu DM, Yuan H, et al. Extract of ginkgo biloba promotes the expression of VEGF following subarachnoid hemorrhage in rats. Int. J. Neurosci. 2009;119:995–1005.
6. Liu X, Jin Y, Zheng H, et al. Arginine vasopressin gene expression in supraoptic nucleus and paraventricular nucleus of hypothalamous following cerebral ischemia and reperfusion. Chin. Acad. Med. Sci. 2000;15:157–161.
7. Pascale CL, Szmydynger-Chodobska J, Sarri JE, et al. Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor. J. Physiol. Pharmacol. 2006;57(Suppl 11):161–167.
8. Sehba FA. Rat endovascular perforation model. Trans. Stroke Res. 2014;5:660–668.
9. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086–1091.
10. Schwartz AY, Masago A, Sehba FA, et al. Experimental models of subarachnoid hemorrhage in the rat: a refinement of the endovascular filament model. J. Neurosci. Methods. 2000;96:161–167.
11. Friedrich V, Flores R, Muller A, et al. Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage. Brain Res. 2010;1354:179–187.
12. Cohen B, Martinelli GP, Ogorodnikov D, et al. Sinusoidal galvanic vestibular stimulation (sGVS) induces a vasovagal response in the rat. Exp. Brain Res. 2011;210:45–55.
13. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press Inc, 1986.
14. Duverger D, MacKenzie ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J. Cereb. Blood Flow Metab. 1988;8:449–461.
15. Fuzik J, Gellert L, Olah G, et al. Fundamental interstrain differences in cortical activity between Wistar and Sprague-Dawley rats during global ischemia. Neuroscience. 2013;228:371–381.
16. Walberer M, Stolz E, Muller C, et al. Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI). Lab. Anim. 2006;40:1–8.
17. Sehba FA, Friedrich V. Cerebral microvasculature is an early target of subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:199–205.
18. Sehba FA, Schwartz AY, Chereshnev I, et al. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2000;20:604–611.
19. Sehba FA, Makonnen G, Friedrich V, et al. Acute cerebral vascular injury occurs after subarachnoid hemorrhage and can be prevented by administration of a Nitric Oxide donor. J. Neurosurg. 2007;106:321–329.
20. Berra LV, Carcereri De Prati A, Suzuki H, et al. The role of constitutive and inducible nitric oxide synthase in the human brain after subarachnoid hemorrhage. J. Neurosurg. Sci. 2007;51:1–9.
21. McCullough LD, Zeng Z, Blizzard KK, et al. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J. Cereb. Blood Flow Metab. 2005;25:502–512.
22. Ito T, Maruyama I. Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation. J. Thromb. Haemost. 2011;9(Suppl 1):168–173.
23. Olivot JM, Labreuche J, Aiach M, et al. Soluble thrombomodulin and brain infarction: Case-control and prospective study. Stroke. 2004;35:1946–1951.
24. Strijbos MH, Rao C, Schmitz PI, et al. Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage. Thromb. Haemost. 2008;100:642–647.
25. Yin YD, Wang C, Zhai ZG, et al. Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism. J. Thromb. Thrombolysis. 2009;27:274–279.
26. Sozen T, Tsuchiyama R, Hasegawa Y, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke. 2009;40:2519–2525.
27. Aihara Y, Kasuya H, Onda H, et al. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke. 2001;32:212–217.
28. Zhang XS, Zhang X, Wu Q, et al. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage. J. Surg Res. 2014;192:206–213.
29. Vikman P, Beg S, Khurana TS, et al. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J. Neurosurg. 2006;105:438–444.
30. Bavbek M, Polin R, Kwan AL, et al. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke. 1998;29:1930-1935; discussion 1935-1936.
31. Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, et al. Interleukin- 1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr Neurovasc Res. 2012;9:159–166.
32. Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J. Korean Med. Sci. 2001;16:774–780.
33. Mack WJ, Mocco J, Hoh DJ, et al. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2002;96:71–75.
34. Hockel K, Scholler K, Trabold R, et al. Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage. Stroke. 2012;43:227–232.
35. Slevin M, Krupinski J, Slowik A, et al. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 2000;31:1863–1870.
36. Polunovsky VA, Wendt CH, Ingbar DH, et al. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp. Cell Res. 1994;214:584–594.
37. Zhang C, Xu X, Potter BJ, et al. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 2006;26:475–480.
38. Simard JM, Geng Z, Woo SK, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2009;29:317-330.
39. Prunell GF, Svendgaard NA, Alkass K, et al. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery. 2005;56:1082–1092.
40. Hanafy KA, Grobelny B, Fernandez L, et al. Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage. J. Neurol. Sci. 2010;291:69–73.
41. Starke RM, Chalouhi N, Jabbour PM, et al. Critical role of TNFalpha in cerebral aneurysm formation and progression to rupture. J. Neuroinflammation. 2014;11:77–87.